Association of non-alcoholic fatty liver disease with glycemic control among patients with type 2 diabetes mellitus at Limbe Regional Hospital, Southwest, Cameroon

Table 2 Comparison of biochemical and clinical characteristics between patients with type 2 diabetes mellitus with and without non-alcoholic fatty liver disease, mean ± SD

Variable	Total (n = 150)	No NAFLD (n = 122)	NAFLD (n = 28)	t-test	P value
TG (mg/dL)	102.23 ± 75.33	86.19 ± 62.59	173.68 ± 84.34	5.172	< 0.001
GGT (U/L)	42.71 ± 24.66	37.36 ± 22.31	65.27 ± 22.01	6.033	< 0.001
HbA1c (%)	5.15 ± 1.49	4.66 ± 0.98	7.82 ± 0.85	1.780	0.085
WC (cm)	75.96 ± 26.25	71.94 ± 22.65	92.29 ± 34.89	2.946	0.006
BMI (kg/m2)	24.49 ± 6.22	24.81 ± 18.32	30.08 ± 7.98	2.349	0.021

BMI: Body mass index; GGT: Gamma-glutamyl transferase; HbA1c: Glycated hemoglobin; NAFLD: Non-alcoholic fatty liver disease; TGs: Triglycerides; WC: Waist circumference.